| | 17902-23-7 Basic information More.. |
| Product Name: | Tegafur | | Synonyms: | 5-fluoro-1-(tetrahydro-3-furyl)uracil;5-fluoro-1-(tetrahydrofuran-2-yl)uracil;coparogin;fluorofur;franroze;Tegafur, >=99%;fulfeel;furafluor | | CAS: | 17902-23-7 | | MF: | C8H9FN2O3 | | MW: | 200.17 | | EINECS: | 241-846-2 | | Mol File: | 17902-23-7.mol |  |
Use
Tegafur (INN, BAN, USAN) is a prodrug of Fluorouracil (5-FU), an antineoplastic agent used as the treatment of various cancers such as advanced gastric and colorectal cancers. It is a pyrimidine analogue used in combination therapies as an active chemotherapeutic agent in conjunction with Gimeracil and Oteracil, or along with Fluorouracil as Tegafur-uracil. Tegafur is usually given in combination with other drugs that enhance the bioavailability of the 5-FU by blocking the enzyme responsible for its degradation, or serves to limit the toxicity of 5-FU by ensuring high concentrations of 5-FU at a lower dose of tegafur.
- Tegafur
-
- 2025-07-21
- CAS:17902-23-7
- Min. Order:
- Purity: 0.99
- Supply Ability:
- Tegafur
-
- US $0.00 / KG
- 2025-07-21
- CAS:17902-23-7
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 500kg/month
- Tegafur
-
- US $97.00-53.00 / mg
- 2025-07-17
- CAS:17902-23-7
- Min. Order:
- Purity: 99.16%
- Supply Ability: 10g
|
|
17902-23-7
Recommend Suppliers |
|